Sinopharm (02453) controlling shareholder Shanghai Medical Star further increased its holding of 95,400 H shares of the company.

Financial news from Zhitong APP, Meizhongjiahe (02453) announced that one of the company's controlling shareholders, Shanghai Medical Star, purchased a total of 45,600 H shares of the company from the open market on May 7, 2025. Shanghai Medical Star further informed the board of directors that it purchased a total of 95,400 H shares of the company from the open market from May 8, 2025 to May 9, 2025, with a total consideration of approximately HK$641,732.00 (an average price of approximately HK$6.73 per share), accounting for approximately 0.01% of the total number of shares issued by the company as of the date of this announcement. This move fully demonstrates Shanghai Medical Star's confidence in the company's future prospects and support for its continued development.